
Three More Rare Disease Focused Biotechs Join Queue of Biotech Restructurings
Read More
Imara Cuts Workforce by 83 Percent, Joining Growing List of Companies Trying to Stay Afloat
Read More
Magenta Joins Growing List of Biotechs Reducing Workforce to Extend Cash Runway
Read More
Rare Disease Focused Biotechs Ovid and Passage Bio Restructure, Conserve Runway
Read More
Orphazyme Begins In-Court Restructuring, Reducing Half of Current Workforce
Read More